Glimsentro-MV1 Tablet SR
Marketer
Sentro Pharma & Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimsentro-MV1 Tablet SR
Diabex-Combo SR tablets are categorized as antidiabetic medications, a combination formulation for adult-onset type 2 diabetes. This medication assists in regulating blood glucose. Diabex-Combo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as cessation without medical guidance can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to identify its symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician prior to use. Pregnant or lactating women require medical consultation before commencing treatment. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimsentro-MV1 Tablet SR
There is no text provided to rephrase.
Uses of Glimsentro-MV1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimsentro-MV1 Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glimsentro-MV1 Tablet SR whole; avoid chewing, crushing, or breaking it. Consume it on an empty stomach.
Common Side effects of Glimsentro-MV1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimsentro-MV1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimsentro-MV1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Glimsentro-MV1 Tablet SR works:
Glimsentro-MV1 sustained-release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glimsentro-MV1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glimsentro-MV1 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimsentro-MV1 Tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimsentro-MV1 Tablet SR is inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is necessary. Patients with severely compromised kidneys should not use Glimsentro-MV1 Tablet SR.
LiverCAUTION
Patients with liver impairment should use Glimsentro-MV1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Glimsentro-MV1 Tablet SR :
Should you forget a dose of Glimsentro-MV1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimsentro-MV1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


